Quantcast Cypress Bioscience 1Q Loss Widens On Expenses - Congoo
 
 
Log In
Cypress Bioscience 1Q loss widens on expenses
Have an interest in this Story?
Sign Up for Real-Time email updates
Forbes.com  | May 12, 2008

Cypress Bioscience Inc. Monday said that its first-quarter loss widened on an increase in operating expenses stemming from the drug developer's acquisition of Propius Pharmaceuticals. The company lost $2.9 million, or 8 cents per share, compared with $1.2 million, or 4 cents per share in the year-ag...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Alexandr Migunov Alexandr Migunov
Consultant
Real Estate Industry
Jaime Neyra Morales Jaime Neyra Morales
Relationship Manager, Commercial Banking
Banking

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.